These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30305425)

  • 1. The structural basis for cancer drug interactions with the catalytic and allosteric sites of SAMHD1.
    Knecht KM; Buzovetsky O; Schneider C; Thomas D; Srikanth V; Kaderali L; Tofoleanu F; Reiss K; Ferreirós N; Geisslinger G; Batista VS; Ji X; Cinatl J; Keppler OT; Xiong Y
    Proc Natl Acad Sci U S A; 2018 Oct; 115(43):E10022-E10031. PubMed ID: 30305425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of cellular dNTP regulation by SAMHD1.
    Ji X; Tang C; Zhao Q; Wang W; Xiong Y
    Proc Natl Acad Sci U S A; 2014 Oct; 111(41):E4305-14. PubMed ID: 25267621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing the Catalytic Mechanism and Inhibition of SAMHD1 Using the Differential Properties of R
    Morris ER; Kunzelmann S; Caswell SJ; Purkiss AG; Kelly G; Taylor IA
    Biochemistry; 2021 Jun; 60(21):1682-1698. PubMed ID: 33988981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SAMHD1 protects cancer cells from various nucleoside-based antimetabolites.
    Herold N; Rudd SG; Sanjiv K; Kutzner J; Bladh J; Paulin CBJ; Helleday T; Henter JI; Schaller T
    Cell Cycle; 2017 Jun; 16(11):1029-1038. PubMed ID: 28436707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The missing link: allostery and catalysis in the anti-viral protein SAMHD1.
    Morris ER; Taylor IA
    Biochem Soc Trans; 2019 Aug; 47(4):1013-1027. PubMed ID: 31296733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia.
    Schneider C; Oellerich T; Baldauf HM; Schwarz SM; Thomas D; Flick R; Bohnenberger H; Kaderali L; Stegmann L; Cremer A; Martin M; Lohmeyer J; Michaelis M; Hornung V; Schliemann C; Berdel WE; Hartmann W; Wardelmann E; Comoglio F; Hansmann ML; Yakunin AF; Geisslinger G; Ströbel P; Ferreirós N; Serve H; Keppler OT; Cinatl J
    Nat Med; 2017 Feb; 23(2):250-255. PubMed ID: 27991919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SAM domain of mouse SAMHD1 is critical for its activation and regulation.
    Buzovetsky O; Tang C; Knecht KM; Antonucci JM; Wu L; Ji X; Xiong Y
    Nat Commun; 2018 Jan; 9(1):411. PubMed ID: 29379009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SAMHD1 enhances nucleoside-analogue efficacy against HIV-1 in myeloid cells.
    Ordonez P; Kunzelmann S; Groom HC; Yap MW; Weising S; Meier C; Bishop KN; Taylor IA; Stoye JP
    Sci Rep; 2017 Feb; 7():42824. PubMed ID: 28220857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substrates and Inhibitors of SAMHD1.
    Hollenbaugh JA; Shelton J; Tao S; Amiralaei S; Liu P; Lu X; Goetze RW; Zhou L; Nettles JH; Schinazi RF; Kim B
    PLoS One; 2017; 12(1):e0169052. PubMed ID: 28046007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural insight into dGTP-dependent activation of tetrameric SAMHD1 deoxynucleoside triphosphate triphosphohydrolase.
    Zhu C; Gao W; Zhao K; Qin X; Zhang Y; Peng X; Zhang L; Dong Y; Zhang W; Li P; Wei W; Gong Y; Yu XF
    Nat Commun; 2013; 4():2722. PubMed ID: 24217394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies.
    Herold N; Rudd SG; Ljungblad L; Sanjiv K; Myrberg IH; Paulin CB; Heshmati Y; Hagenkort A; Kutzner J; Page BD; Calderón-Montaño JM; Loseva O; Jemth AS; Bulli L; Axelsson H; Tesi B; Valerie NC; Höglund A; Bladh J; Wiita E; Sundin M; Uhlin M; Rassidakis G; Heyman M; Tamm KP; Warpman-Berglund U; Walfridsson J; Lehmann S; Grandér D; Lundbäck T; Kogner P; Henter JI; Helleday T; Schaller T
    Nat Med; 2017 Feb; 23(2):256-263. PubMed ID: 28067901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uncovering allostery and regulation in SAMHD1 through molecular dynamics simulations.
    Patra KK; Bhattacharya A; Bhattacharya S
    Proteins; 2017 Jul; 85(7):1266-1275. PubMed ID: 28321930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of T592 phosphomimetic mutations on tetramer stability and dNTPase activity of SAMHD1 can not explain the retroviral restriction defect.
    Bhattacharya A; Wang Z; White T; Buffone C; Nguyen LA; Shepard CN; Kim B; Demeler B; Diaz-Griffero F; Ivanov DN
    Sci Rep; 2016 Aug; 6():31353. PubMed ID: 27511536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p21 Restricts HIV-1 in Monocyte-Derived Dendritic Cells through the Reduction of Deoxynucleoside Triphosphate Biosynthesis and Regulation of SAMHD1 Antiviral Activity.
    Valle-Casuso JC; Allouch A; David A; Lenzi GM; Studdard L; Barré-Sinoussi F; Müller-Trutwin M; Kim B; Pancino G; Sáez-Cirión A
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of allosteric activation of sterile α motif and histidine-aspartate domain-containing protein 1 (SAMHD1) by nucleoside triphosphates.
    Koharudin LM; Wu Y; DeLucia M; Mehrens J; Gronenborn AM; Ahn J
    J Biol Chem; 2014 Nov; 289(47):32617-27. PubMed ID: 25288794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase.
    Goldstone DC; Ennis-Adeniran V; Hedden JJ; Groom HC; Rice GI; Christodoulou E; Walker PA; Kelly G; Haire LF; Yap MW; de Carvalho LP; Stoye JP; Crow YJ; Taylor IA; Webb M
    Nature; 2011 Nov; 480(7377):379-82. PubMed ID: 22056990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The crystal structure of dGTPase reveals the molecular basis of dGTP selectivity.
    Barnes CO; Wu Y; Song J; Lin G; Baxter EL; Brewster AS; Nagarajan V; Holmes A; Soltis SM; Sauter NK; Ahn J; Cohen AE; Calero G
    Proc Natl Acad Sci U S A; 2019 May; 116(19):9333-9339. PubMed ID: 31019074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functionality of Redox-Active Cysteines Is Required for Restriction of Retroviral Replication by SAMHD1.
    Wang Z; Bhattacharya A; White T; Buffone C; McCabe A; Nguyen LA; Shepard CN; Pardo S; Kim B; Weintraub ST; Demeler B; Diaz-Griffero F; Ivanov DN
    Cell Rep; 2018 Jul; 24(4):815-823. PubMed ID: 30044979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution structures of the SAMHD1 dGTPase homolog from Leeuwenhoekiella blandensis reveal a novel mechanism of allosteric activation by dATP.
    Klemm BP; Sikkema AP; Hsu AL; Horng JC; Hall TMT; Borgnia MJ; Schaaper RM
    J Biol Chem; 2022 Jul; 298(7):102073. PubMed ID: 35643313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and functional characterization explains loss of dNTPase activity of the cancer-specific R366C/H mutant SAMHD1 proteins.
    Bowen NE; Temple J; Shepard C; Oo A; Arizaga F; Kapoor-Vazirani P; Persaud M; Yu CH; Kim DH; Schinazi RF; Ivanov DN; Diaz-Griffero F; Yu DS; Xiong Y; Kim B
    J Biol Chem; 2021 Oct; 297(4):101170. PubMed ID: 34492268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.